Schizophrenia is associated with a broad range of severe and currently pharmacoresistant cognitive deficits. Prior evidence suggests that hypofunction of AMPA-type glutamate receptors (AMPARs) containing the subunit GLUA1, encoded by GRIA1, might be causally related to impairments of selective attention and memory in this disorder, at least in some patients. In order to clarify the roles of GluA1 in distinct cell populations, we investigated behavioural consequences of selective Gria1-knockout in excitatory neurons of subdivisions of the prefrontal cortex and the hippocampus, assessing sustained attention, impulsivity, cognitive flexibility, anxiety, sociability, hyperactivity, and various forms of short-term memory in mice. We found that virally induced reduction of GluA1 across multiple hippocampal subfields impaired spatial working memory. Transgene-mediated ablation of GluA1 from excitatory cells of CA2 impaired short-term memory for conspecifics and objects. Gria1 knockout in CA3 pyramidal cells caused mild impairments of object-related and spatial short-term memory, but appeared to partially increase social interaction and sustained attention and to reduce motor impulsivity. Our data suggest that reduced hippocampal GluA1 expression—as seen in some patients with schizophrenia—may be a central cause particularly for several short-term memory deficits. However, as impulse control and sustained attention actually appeared to improve with GluA1 ablation in CA3, strategies of enhancement of AMPAR signalling likely require a fine balance to be therapeutically effective across the broad symptom spectrum of schizophrenia.
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors (AMPARs) containing the GluA1 subunit are essential for synaptic plasticity [1,2,3,4] and have been implicated in a variety of processes related to psychiatric diseases. For example, GluA1-containing AMPARs in prefrontal excitatory cells are essential downstream targets mediating the maintenance of the anti-depressant response to ketamine in rodents . The same receptors are also modulated specifically by alpha2-adrenoreceptors, the target of the attention-deficit-hyperactivity disorder drug guanfacine . Most prominently, GLUA1 has been implicated in schizophrenia . GRIA1, the gene encoding GLUA1, has been identified as a risk gene for this disease in genome-wide association studies [8,9,10]. Decreased GRIA1 mRNA and protein levels have been found in hippocampal tissue from schizophrenia patients in three studies using either in situ hybridisation (ISH) or autoradiography, respectively [11,12,13]. Although note that three other studies using ISH or Western Blot, respectively, did not find significantly altered GRIA1 expression in hippocampi from schizophrenia patients [14,15,16]. This suggests that a hypofunction of GLUA1 may be one out of multiple molecular pathological alterations that can each impair synaptic function in the hippocampus [17, 18] and thereby causally contribute to schizophrenia.
Global Gria1 ablation in mice has been used to model certain deficits of synaptic plasticity, dopamine regulation and associated psychological functions related to schizophrenia [7, 19, 20]. Gria1-knockout (Gria1−/−) mice show severe impairments of spatial short-term memory and of attentional regulation of novelty-related salience attribution to objects, spatial and non-spatial cues [7, 21, 22], while, at the same time, they retain the ability to form spatial long-term memories [23, 24]. GluA1-related failures of salience attribution are likely driven by impaired short-term habituation , a psychological mechanism that reduces attention paid to stimuli as they become familiar [7, 25], and whose failure may cause excessive novelty-induced hyperlocomotion and impaired spatial and non-spatial novelty preference in rodents. Gria1-knockout also provokes a hyperdopaminergic state in the striatum —indicative of aberrant salience attribution [20, 25, 27]—and defective pre-pulse inhibition .
However, the clinical strategy of enhancing AMPAR function indiscriminately with AMPAkines has been met with mixed results [28,29,30]. In order to evaluate the enhancement of GluA1-AMPAR function as a therapeutic concept in schizophrenia, it is vital to understand through which cell types and neural circuits GluA1 hypofunction may contribute to specific psychiatric deficits and to identify its broader contributions to cognition. However, circuit- or cell-type-specific studies of GluA1-functions were so far limited to assessments of short-term memory in mice with either broader but mosaic restoration of forebrain or hippocampal GluA1 expression in Gria1−/− mice [31,32,33,34] or with Cre-mediated ablation in parvalbumin interneurons  or in different hippocampal subdivisions . We have recently identified a specific role of GluA1 in the CA2/CA3 subfields of the hippocampus, as impaired spatial short-term habituation in Gria1−/− mice could be restored by viral reintroduction of GluA1 into these circuits . It remains to be clarified, however, which cell types and subfields are responsible for this rescue and whether the role of GluA1 in CA2/3 GluA1 extends to other schizophrenia-related phenotypes. For example, it is uncertain which GluA1-containing AMPARs support short-term memory performance across different tasks [31, 33]. To dissect the role of GluA1 in distinct neuronal circuits, here we examined the behavioural consequences of Gria1 ablation in excitatory cells of either prefrontal cortex or hippocampus in a broad battery of behavioural assays, including back-translational tasks relevant to schizophrenia.
All experiments were performed in accordance with the German Animal Rights Law (Tierschutzgesetz) 2013 and the European Union regulations for the use of laboratory animals (EU Directive 2010/63), and were approved by the Federal Ethical Review Committee (Regierungspräsidium Tübingen) of Baden-Württemberg, Germany (license number TV1399). To enable region- and excitatory cell-type selective Gria1-ablation, mice with a homozygously floxed Gria1-locus (Gria1f/f, B6N.129-Gria1tm2Rsp/J; also known as GluR-A [2lox], Jax stock# 019012) were either infused with a Cre- or a GFP-expressing rAAV-vector (AAV8-CamKIIα-GFP-Cre for Gria1-knockout, AAV8-CamKIIα-GFP for controls; UNC vector core; AAV-cohort) at 6 months of age, on average, or were cross-bred with Cre-driver lines in which promoters directed Cre-expression to excitatory cells of either CA2 (TgAmigo2-Cre, B6.Cg-Tg(Amigo2-cre)1Sieg/J, Jax stock# 030215)  or CA3 (Grik4-Cre, C57BL/6-Tg(Grik4-cre)G32-4Stl/J, Jax-stock# 006474) , transgenic cohort. In the latter cases, breedings between Gria1f/f x TgAmigo2-cre and Gria1f/f x TgGriK4-cre genotypes were performed to obtain Gria1ΔAmigo2 and Gria1ΔGriK4 offsprings and their Gria1f/f controls (Gria1Ctrl). For the transgenic approach, mixed male-female cohorts (11–12 males and 7–8 females per subgroup) were used, while male-only cohorts were used for the viral approach, as the larger cohorts required for mixed-sex cohorts were not logistically possible due to the time requirements of surgeries and the 5-CSWM-task training (see below). Subgroup sizes were chosen according to our previous data in the respective behavioural tests [39,40,41]. Surgery was conducted as described previously  and in Supplementary Methods. Mice were housed in individually ventilated cages (IVC) containing sawdust, sizzle nest and one cardboard ‘house’ (Datesand, UK) as enrichment, throughout. Temperature (ca. 22 °C), humidity (45–65%) and illumination within a 13 h light/11 h dark cycle (with the light phase starting at 7 a.m.) were tightly maintained within the animal holding room. Where possible, mice were kept in groups of 2–5/cage with ad libitum access to water throughout, and to food prior to and in the interludes between experiments that required appetitively motivated learning. For the latter, mice were kept on food restriction with weights at ~85–95% of their average individual weights under ad libitum food access.
Behavioural experiments started at 2 or 7 months of age in the transgenic and AAV cohorts, respectively, and were conducted during the light phase by an experimenter blind to group identity. The T-maze rewarded alternation and the operant delayed-match-to-place (DMTP) 5-choice (5-CSWM) tests of spatial working memory (SWM), the Y-maze test of spatial novelty preference (SNP), the novel object-recognition test (NOR), the elevated plus-maze (EPM) test of unconditioned anxiety, novelty-induced locomotion, nest-building, the 5-choice serial reaction-time task (5-CSRTT) and related operant rule-shift assays were each conducted as previously described [39, 42, 43] (also detailed in Supplementary Methods). Operant tasks were all conducted in custom-designed 5-choice operant boxes [44, 45].
For reciprocal social interaction, the test mouse was exposed to a younger, adult, same-sex novel stimulus mouse in a familiar open field (dark but transparent Type III cage; Tecniplast, G) and interactions were video-monitored and scored in 2 min intervals for either 12 min (transgenic cohorts) or 16 min (AAV-cohort) . For non-reciprocal interaction, a modified 3-chamber task was utilised, similarly to that used previously to assess sociability in mice with impaired synaptic release from CA2-excitatory cells (see Fig. 4f) : all mice were habituated to the situation of a stimulus mouse by being placed in a half-circular compartment (9 cm radius, perforated metal) at either end of the 3-chamber testing box (50 cm long, 20 cm wide, 25 cm high grey PVC walls) for 2 × 5 min on the previous day and then again once more for 5 min 1–2 h before testing on the first test day. In the first test session, mice were first habituated to the arena without metal compartments (5 min), then to the arena with empty metal compartments (5 min), and were then exposed to a cagemate in one of the empty metal compartments while a mouse-sized piece of black foam was introduced to the other compartment (social preference test, 5 min). The second testing session was conducted on the next day and consisted of four phases: (i) 5 min habituation to the 3-chamber box with empty metal compartments, (ii) 5 min exposure to an unfamiliar stimulus mouse in one compartment and the same cagemate that they had seen on the previous day in the other compartment to assess social novelty preference based on long-term memory (the position of the familiar mouse was counterbalanced within subgroup); (iii) 10 min habituation to the novel mouse from phase 2 (with the other compartment empty) and (iv) 5 min exposure to the mouse from phase 2 and an unfamiliar stimulus mouse to assess social short-term memory (the position of the novel mouse was counterbalanced within groups).
Prior to analysis, some animals were excluded due to insufficient bilateral expression of AAV-transduced Cre (3 dPFC-KO, 2 HC-KO mice), or, in each individual behavioural assay, due to insufficient participation in the assay. Statistical analyses were performed using SPSS (IBM). Two-way repeated-measures analyses of variance (two-way RM-ANOVA) was used in experiments that included multiple challenge protocols, training data, or a baseline measure before a challenge. One-way univariate ANOVA was used on normally distributed data with a simple between-subjects design. Non-parametric Kruskal-Wallis ANOVA or the Mann–Whitney U (MWU) test were used, as applicable, when the normality of the data was not assumed. A P < 0.05 was considered statistically significant. All data are presented as mean values ± standard error (s.e.m.) or as dot plots representing the values of each individual animal. Detailed statistical results for all experiments are shown in Supplementary Tables 1–4.
Spatial working memory impairment in mice with hippocampal ablation of GluA1
To assess if hypofunction of GluA1-containing AMPARs in excitatory cells of the prefrontal cortex or the hippocampus causes schizophrenia-related deficits, we virally transduced either dorsal PFC (anterior cingulate cortex, ACC, and upper prelimbic cortex, PrL), PrL more exclusively, or the hippocampus of Gria1f/f mice with either GFP-tagged Cre recombinase (Cre groups) or GFP only (control groups) driven by the CamKIIα-promoter, bilaterally (Fig. 1a and Supplementary Fig. 1). For analysis, mice with prefrontal transductions were treated as a separate cohort from mice with hippocampal injections, each with their own control group. Cre-transduction led to a strong reduction of GluA1-positive cells (Fig. 1a–c and Supplementary Fig. 1). As is typical for virus-mediated transductions, expression was mosaic across the cell populations of the targeted areas. With our hippocampal injections, there was minimal bilateral coverage of the CA1 subfield or of the ventral hippocampus, but dorsal CA2/3 was transduced bilaterally in every mouse (Fig. 1a and Supplementary Fig. 1).
After recovery from surgery, rAAV-transduced Gria1f/f mice were first trained in the DMTP operant working memory task (5-CSWM) which involved multiple stages . In this operant task, mice need to memorise which one out of five holes they had poked into during the prior sample phase while shuttling to the opposite wall of the operant box during the delay, and then poke into the same hole in the choice phase (Fig. 1d). After training, mice were tested with different challenge protocols placing high demands on working memory performance as a result of either distractions during the delay phase or increased delay. Cre-transduced mice of any of the hippocampal or prefrontal groups did not differ from their respective control groups in any protocol (Fig. 1e; see Supplementary Tables 1 and 2 for statistics on this and all subsequent tests in the AAV-cohort).
Later, these mice were trained in the T-maze rewarded alternation SWM task, which utilises a delayed-non-match-to-place paradigm . While Cre-transduction into dPFC and PrL did not affect performance during training or with different delay-challenge protocols in this task, Cre-transduction in the hippocampus impaired performance over the training period (P = 0.0036, effect of the group; repeated-measures ANOVA across 7 training days; Fig. 1f, g). While the effect of the group remained a trend with a 1 s delay massed-trials protocol (P = 0.058, univariate ANOVA), it was not detected with a longer delay of 20 s reflecting the reduced performance in controls (Fig. 1f, g). In contrast to global Gria1−/− mice [23, 33], however, performance was significantly above chance level under all conditions (P < 0.05, one-sample t-test). In the Y-maze spatial novelty-preference test, there was no impairment in the hippocampal group (Fig. 1h).
To test whether sustained attention was affected, mice were trained in the 5-CSRTT, in which mice need to wait and detect a brief illumination of one of the holes in the 5-choice wall in order to be rewarded [39, 43]. This task resembles the sample phase of the 5-CSWM task on which the mice had been trained before. There was no effect of group on measures of sustained attention, task engagement, motivation, perseveration, or impulse control assessed in this task in the baseline training protocol nor in a protocol in which sustained attention was challenged by reduction of the stimulus duration to 1 s applied on the next day (Fig. 1i and Supplementary Table 1). Subsequently, the task was modified to a simpler two-choice task with a longer stimulus duration (8 s). Once mice responded to the illuminated hole with an accuracy of 80% on 2 consecutive days, the task rule was changed to assess cognitive flexibility. Under the new rule, poking of one specific hole of the 5-choice wall (hole 2 or 4) was rewarded irrespective of whether it was illuminated. Cre-transduced mice of all groups learned the new rule at a similar speed as their respective GFP-transduced controls (Fig. 1j, k).
Finally, we assessed several non-cognitive behavioural functions. Both, unconditioned anxiety on the EPM and— in stark contrast to the hyperlocomotion phenotype of Gria1−/− mice —novelty-induced locomotion in an open field were reduced in mice with hippocampal GluA1 knockout compared to their control group, but were unaffected by prefrontal GluA1 ablation (Fig. 1l and Supplementary Fig. 2). In contrast, reciprocal social interaction was unaltered by hippocampal GluA1 ablation but showed a trend towards an increase with prefrontal GluA1 ablation (Supplementary Fig. 2).
In summary, we found no evidence that GluA1 hypofunction in excitatory cells of the prefrontal cortex contributes to cognitive deficits related to schizophrenia in the battery of tests adopted here, whereas reduction of GluA1 in hippocampal excitatory cells may be responsible for at least some of the short-term memory deficits seen in this disorder.
Gria1-knockout in excitatory cells of CA2 or CA3 causes mild hyperlocomotion
To further elucidate the potential role of hippocampal GluA1-containing AMPARs, we employed a transgenic approach to achieve more complete targeting of specific populations of excitatory cells, namely those of either the CA2-subfield (targeted by the Amigo2-Cre-driver line ; Gria1ΔAmigo2) or of the CA3 subfield (targeted by the Grik4-Cre-driver line ; Gria1ΔGrik4). These two hippocampal regions were implicated in spatial short-term memory by our previous rescue study in Gria1−/− mice , as well as by the experiments described above (Fig. 1f). Gria1ΔAmigo2 and Gria1ΔGrik4 mice showed a noticeable attenuation of GluA1 expression in the CA2 and CA3 subfields, respectively (Fig. 2a).
Given the prior null results of the AAV-cohort in the labour-intensive 5-CSWM task, this task was omitted from the test battery, and unrewarded exploration-based assays were conducted first (Fig. 2b). Like mice with virally mediated GluA1 ablation in the hippocampus (Fig. 1l), Gria1ΔAmigo2—but not Gria1ΔGrik4—mice showed a marginally higher preference for entries into the open arm of the EPM, potentially indicating reduced anxiety (Fig. 2c; see Supplementary Tables 3 and 4 for statistical assessment of all behavioural tests conducted in the transgenic cohorts). However, they also displayed a reduced average distance from the sidewall of the open field, which could indicate higher anxiety (Fig. 2d). This suggests that there is no clear phenotype for anxiety levels in Gria1ΔAmigo2 mice, reminiscent of findings from global Gria1−/− mice . Both Gria1ΔAmigo2 and Gria1ΔGrik4 mice displayed a mild increase in novelty-induced locomotion in both the open field and EPM (Fig. 2e–i), although far from the pronounced hyperlocomotion phenotype consistently seen in Gria1−/− mice exposed to spatial novelty [26, 33, 47].
GluA1 hypofunction in CA2 and CA3 impairs distinct modalities of short-term memory
Short-term habituation to sensory stimuli is markedly impaired in global Gria1−/− mice, resulting in deficits of object-related and spatial novelty preference in the novel object-recognition and Y-maze tests, respectively [7, 21, 22]. We conducted both tests in the Gria1ΔAmigo2 and Gria1ΔGrik4 mice. GluA1 ablation from CA3—but not CA2—excitatory cells caused reduced spatial novelty preference in terms of entries into the novel vs. the familiar arm at a younger age and in terms of time spent in the novel vs. the familiar arm at the older age (Fig. 3a–c). At an older age, spatial novelty preference also differed in dependence on the sex of the mice, which was otherwise not observed in most behavioural tests where females were also assessed (Supplementary Tables 3 and 4 and Supplementary Fig. 3).
In contrast, a deficit in novel object recognition was seen in both Gria1ΔAmigo2 and Gria1ΔGrik4 mice. Notably, Gria1ΔAmigo2 mice also displayed strongly increased exploration of objects in all phases of the task, arguing for a potentially stronger deficit of object-related short-term habituation in these animals (Fig. 3d–g).
Given the profound rewarded alternation deficit in the T-maze in mice with virally mediated GluA1 ablation in the hippocampus (Fig. 1f), we conducted the same T-maze training and testing schedule in the transgenic cohorts. Surprisingly, there was no consistent deficit in either one of these two groups, apart from a mildly reduced performance during the initial T-maze training in Gria1ΔAmigo2 mice (Fig. 3h, i).
Altered social behaviour and social memory in Gria1 ΔAmigo2 mice
Ablation of synaptic release from Amigo2-positive neurons in the hippocampus was shown previously to produce a deficit in social short-term memory . But whether AMPARs in CA2 pyramidal cells are involved in social behaviour is unknown. Therefore, we first conducted a reciprocal sociability test in a familiar environment at 3 months of age. We found that Gria1ΔAmigo2—but not Gria1ΔGrik4—mice showed strongly reduced social interaction (Fig. 4b–d). At 10 months of age, we repeated the test and found sociability to be normal (Fig. 4b–d), possibly suggesting an age-dependent phenotype. At this later age, we also applied the 3-chamber task to assess both sociability and social memory. The task was designed to discriminate between alterations of genuine social short-term memory and alterations of social novelty preference, as such, by testing separately for the preference for a novel mouse over a long-term cagemate  (see 'Methods'; Fig. 4f). During the sociability phase, we found that Gria1ΔAmigo2 mice were normal, but Gria1ΔGrik4 mice showed increased social interaction (Fig. 4g). (We have reported previously that global Gria1−/− mice may show very distinct levels of social interaction, depending on the level of prior habituation to the social arena —a phenomenon, that may underlie the discrepancies between the different social tests conducted in this study.) While both transgenic GluA1-ablation models showed a normal preference for a novel conspecific over a known cagemate, only Gria1ΔAmigo2 mice showed a deficit in social short-term memory indicated by a chance-level preference score (P > 0.3, one-sample t-test; note that due to high variability the difference to control mice reached only trend level; Fig. 4g). Their social memory deficit was unlikely to reflect an olfactory impairment, as we did not find an olfactory deficit in Gria1ΔAmigo2 mice (Supplementary Fig. 3). As a related aspect of social behaviour, we also assessed nest-building—but found no alteration in animals of either one of the lines (Supplementary Fig. 3).
GluA1 ablation from CA3 excitatory cells enhances sustained attention and impulse control
To assess the effects of hippocampal GluA1 ablation on sustained attention, the transgenic cohorts were trained in the 5-CSRTT. Once they achieved stable baseline performance on the final training protocol (stage 5), the mice were tested in five different challenge protocols that demanded elevated sustained attention (due to a reduction of the stimulus duration to 1 s or 0.8 s, or pseudo-random auditory distraction) or impulse control (either due to a fixed extension of the ITI to 9 s or a pseudo-randomly varied extension of the ITI-duration; Supplementary Table 6). Gria1ΔAmigo2 mice did not show any major alterations across the parameters assessed by the 5-CSRTT including parameters for sustained attention (accuracy), impulsivity (premature responding), task engagement (omission rates), motivation (reward latency), or general performance (number correct responses; Fig. 5a–c). The exception to this was a reduction of perseverative responding seen in two protocols (Fig. 5c and Supplementary Table 3).
In striking contrast, Gria1ΔGrik4 mice showed a consistent reduction of premature responding across protocols and a reduction in the number of incorrect responses in most attention-related challenges and in the baseline protocol, driving an improvement of attentional accuracy (Fig. 5d, e and Supplementary Table 4). Even the variability of response latencies—which is the primary attention parameter in the human version of this task (although not commonly used in rodents)—was reduced by GluA1 ablation in CA3 in two of the attention challenges and the vITI condition (Fig. 5f). Reward latency, the number of correct responses, omissions and perseveration were not significantly altered. In summary, this overall pattern of a selective reduction of those active response types that are erroneous suggests an improvement in aspects of impulse control and sustained attention in Gria1ΔGrik4 mice.
Decreased cognitive flexibility in Gria1 ΔAmigo2 mice
A related psychological function is cognitive flexibility, one form of which is the capacity to recognise and learn a changing rule. To assess visual rule-shift learning, we trained the mice on a simplified form of the 5-CSRTT, applying an extended stimulus duration and involving only two choices. We then switched the rule from one where the reward was dependent on the light cue to one based on a spatial association with the reward (with the hole illumination now being irrelevant, as described previously for the AAV-cohort; Fig. 1j) . In contrast to the results from the 5-CSRTT, Gria1ΔGrik4 mice—although scoring qualitatively higher than their respective control group—were not significantly better at rule-shift learning by any metric (Fig. 5h–k and Supplementary Fig. 3). However, Gria1ΔAmigo2 mice performed significantly worse than their controls across the first 15 d of testing with the new rule (Fig. 5h). While their perseverative responding (errors that would have been correct responses by the old rule) was marginally higher, the main driver for their reduced accuracy was a strong reduction in correct responses in trials that required the application of the new rule (Fig. 5i–j). This implies that mice were able to recognise that the rule had changed but were less capable of acquiring the new rule—a phenomenon we have observed before in mice with elevated hippocampal activity . Even the number of correct responses on trials where old and new rules were not contradicting each other (i.e., the spatially correct hole was also lit) was decreased, indicating reduced ability to grasp the overall rule-set.
In this study, using different ablation models, we show that GluA1-containing AMPARs in hippocampal—but not prefrontal—excitatory cells are relevant for a wide range of cognitive functions across a behavioural spectrum relevant to schizophrenia (summarised in Table 1). Most prominently, GluA1 ablation in excitatory cells of the hippocampus impaired short-term memory, whereby the specifically affected modality—spatial, object-related or social memory—depended on the manipulated hippocampal subfield. Strikingly, hippocampal GluA1 ablation could entail not only impairments but also enhancements of behavioural performance (Table 1). These results have multiple neuropsychological and translational implications.
Causal association of short-term memory with GluA1 in distinct hippocampal subfields
Despite some degree of variability across experiments, an otherwise clear picture emerges of impaired short-term memory in mice lacking GluA1 in the CA2 and/or CA3 hippocampal subfields (Table 1). This is consistent with our previous study demonstrating a rescue of a form of spatial short-term memory, assessed by spatial novelty preference, with the reintroduction of GluA1 into this region . Notably, in a parallel study using transgenic mice in which GluA1 was ablated from both CA1 pyramidal cells and dentate gyrus granule cells under the control of the CN-12 promotor line , we have found no evidence of any short-term memory impairment (e.g., on the T-maze rewarded alternation task or the Y-maze spatial novelty-preference task; Lee et al., in preparation). This suggests that GluA1-dependent synaptic plasticity in the CA2/CA3 subfields may be particularly important for these short-term memory processes (as discussed previously ). That said, it is also important to point out that the magnitude of the memory deficits reported here (and before ) in regionally selective knockouts are considerably less than what we have reported previously in global GluA1-knockout animals [21,22,23,24]. This suggests a combinatorial effect whereby GluA1 elsewhere in the brain is also relevant for short-term memory which may allow for compensation following the loss of GluA1 in one specific hippocampal subfield.
Nevertheless, the variable patterns of impairments and sparings in the different hippocampal knockout models we have used, across various tasks, are somewhat surprising and not easily explained. For example, within assays of spatial short-term memory, GluA1 hypofunction specifically in the CA3 pyramidal cells of Gria1ΔGrik4 mice reduced spatial novelty preference in the Y-maze but not T-maze rewarded alternation whereas more widespread, but less complete, GluA1 ablation across principal cells of all hippocampal subfields in the Gria1ΔHC mice impaired T-maze SWM performance but not Y-maze novelty preference. These tasks may differ in their sensitivity, the cues that are used, as well as the psychological processes that may be required. Importantly, the clear dissociation between the T-maze rewarded alternation task and the spatial novelty-preference Y-maze task suggests that, at least under some circumstances, rewarded alternation may not merely reflect the spatial short-term habituation processes that support spatial novelty preference , and, conversely, the latter does not necessarily reflect spatial working memory. Likewise, virally mediated hippocampal GluA1 hypofunction did not worsen spatial operant DMTP working memory, but alternation-based DNMTP working memory on the T-maze— which is the reverse phenotype of what we have observed with prefrontal NMDAR-ablation  and which confirms that these two spatial working memory tasks are mediated by different mechanisms, as we recently suggested based on physiological data .
We have argued previously that impaired short-term habituation may be a key pathological mechanism towards the aberrant assignment of salience in schizophrenia [7, 20, 25, 27, 51] and that GluA1 in CA2/CA3 is key in regulating spatial short-term habituation via functional connectivity in the theta frequency range (theta coherence) . The present data suggest that it is GluA1 in CA3, rather than CA2, that supports spatial short-term habituation (as indicated by reduced Y-maze spatial novelty preference in the Gria1ΔGrik4 mice), although even the Gria1ΔGrik4 animals were markedly less affected than global Gria1−/− mice [24, 33, 47]. In contrast, short-term memory for objects was affected more severely in Gria1ΔAmigo2 mice compared to Gria1ΔGrik4 mice (as evident from their increased object exploration, not seen in the latter group), and short-term memory for social stimuli was impaired only in Gria1ΔAmigo2 mice. These results suggest that the short-term memory mechanisms underpinning short-term habituation in the hippocampus may be supported by different hippocampal circuits depending on the type of stimulus that is being processed, which presumably reflects differences in the information that is received by the CA2 (social novelty) and CA3 (contextual novelty) subfields and their distinct anatomical inputs [52, 53]. Altogether, our results demonstrate that seemingly similar psychological functions are dissociable to a surprising degree.
Possible cognitive functions of GluA1 in CA2-excitatory cells
Excitatory cells of CA2 have been implicated previously as central to social short-term memory [37, 54, 55]. Our present data confirm this association, demonstrating impaired social short-term memory in Gria1ΔAmigo2 mice (Fig. 4g), and suggest that this cognitive function relies on GluA1-dependent synaptic plasticity within CA2-excitatory cells. Interestingly, our results also point beyond a social function of CA2. In line with a more general role of CA2 in novelty-processing , Gria1ΔAmigo2 mice also displayed mildly elevated spatial novelty-induced hyperlocomotion, strong increases of object exploration and impairments of novel object recognition (i.e., novel object preference), mild deficits during the acquisition of the T-maze rewarded alternation task and the rule-shift assay. This phenotypic pattern points to a principle difficulty in the appropriate processing of salient stimuli, a central pathology in schizophrenia (often referred to as aberrant salience [25, 27, 51]) which can lead to maladaptive learning, extending beyond the social domain. Notably, impaired performance in short-term memory tests and in reversal learning (a different measure of cognitive flexibility) correlates with impaired salience attribution in patients with schizophrenia [56,57,58] suggesting a common, possibly salience-related mechanism.
Given that Amigo2 expression is more extensive both inside and outside the hippocampus early during development , with our use of a transgenic approach (to ensure complete GluA1 ablation in CA2) we cannot completely rule out the possibility that GluA1 ablation outside CA2 (although, evidently not in the prefrontal cortex, Fig. 1) contributed to this phenotype. The extent of any non-hippocampal ablation is difficult to evaluate due to the much lower native GluA1 expression outside the hippocampus (Fig. 2a), the mosaic and time-dependent distribution of Amigo2 expression during development , and the dependence of the stochastic Cre-lox-recombination on the distance between lox-sites  which is smaller in typical fluorescent reporter lines (e.g., 838 bp in the widely used Ai9 and Ai14 tdTomato Cre-reporter lines ) than in the floxed Gria1 line (1628 bp) . Therefore, the possibility of an association between CA2 and processing of non-social stimuli needs to be further scrutinised in future using virally mediated local manipulations  in combination with the tasks described here.
Regulation of impulse control and attention by GluA1 in CA3 excitatory cells
Psychological functions that are necessary for efficient, adaptive goal-directed behaviour include impulse control, sustained attention, and cognitive flexibility. These functions have mainly been associated with prefrontal circuits [62,63,64], although some evidence for mildly reduced sustained attention and impulse control (as assessed by the 5-CSRTT) resulting from hippocampal manipulations does exist [25, 44, 65,66,67]. Our finding that Gria1ΔGrik4 mice showed a selective and profound reduction of response time variability and of active erroneous responses that would result from decreased attention or increased impulsivity in the 5-CSRTT pinpoints the CA3 subfield, its excitatory cells and GluA1-AMPARs within these cells as key regulators of sustained attention and impulse control. Since GluA1-AMPARs mediate the early phase of hippocampal long-term potentiation (LTP) [1, 2, 4, 68, 69]—including plasticity at synapses of recurrent excitatory connections within CA3 —this suggests that GluA1-induced short-term synaptic enhancement might be a mechanism for adjusting levels of attention and impulsivity during goal-directed behaviours. Notably, virally mediated ablation of NMDA receptors from excitatory cells in CA3 produced a somewhat reversed phenotype compared to that of Gria1ΔGrik4 mice, with elevated motor impulsivity and reduced social interaction .
Implications for treatment strategies
Surprisingly, our data would seem to suggest that GluA1 hypofunction in excitatory cells is not unequivocally detrimental for cognitive performance. Aside from recurring deficits in short-term memory resulting from hippocampal GluA1-KO, we also observed phenotypes that appear to be the opposite of the reduced sociability and impaired attention observed in patients with schizophrenia [71, 72]. Notably, these phenotypes may reflect the more salient presentation specifically of familiar sensory stimuli as is caused by a failure of short-term habituation in global Gria1−/− mice and associated with increased dopamine release [7, 20, 22]. In either case, this has important implications for the pharmacological strategy of enhancing AMPAR function in schizophrenia. So far, non-specific pharmacological augmentations of AMPARs have been developed in the form of ampakines, which enhance hippocampal long-term potentiation . In line with our present data, the ampakines CX516 and faramptor can improve short-term memory performance in healthy humans [29, 74, 75], and a more recent clinical trial (NCT01749098) with the ampakine PF-04958242 demonstrated its ability to improve ketamine-induced working memory deficits in healthy volunteers . However, outside the domain of short-term memory, evidence is more equivocal. For example, the effects of ampakines on long-term memory are mixed [28, 29]. Also, after a promising small clinical trial , CX516 was not found to be effective in improving cognition in patients with schizophrenia . Therefore, further development of the ampakine drug class might instead resort to compounds with modulatory effects, rather than agonists, to limit AMPAR enhancement to activity that is endogenously ongoing. For example, the positive allosteric modulator TAK-137 improved psychostimulant-induced hyperlocomotion, as well as social interaction, working memory, sustained attention, and reversal learning in rodents and non-human primates in the naive state or in pharmacological NMDAR-hypofunction models (MK-801, ketamine) . In line with our present findings, this demonstrates that the restoration of appropriate levels of AMPAR function—and hence GluA1-dependent plasticity—rather than their blunt enhancement, could be therapeutically more effective. Furthermore, the mixed and partly mild behavioural phenotypes in our cell-type-selective Gria1-ablation models align not only with such treatment studies but also with genetic studies [18, 78, 79], suggesting that many different molecular alterations can contribute to schizophrenia by causing synaptic dysfunction in the hippocampus. Pharmacological manipulation of one receptor may not be effective in correcting such diverse synaptic pathologies in every patient population.
Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science. 1999;284:1805–11.
Hoffman DA, Sprengel R, Sakmann B. Molecular dissection of hippocampal theta-burst pairing potentiation. Proc Natl Acad Sci USA. 2002;99:7740–5.
Diering GH, Huganir RL. The AMPA receptor code of synaptic plasticity. Neuron. 2018;100:314–29.
Erickson MA, Maramara LA, Lisman J. A single brief burst induces GluR1-dependent associative short-term potentiation: a potential mechanism for short-term memory. J Cogn Neurosci. 2009;22:2530–40.
Duman RS, Shinohara R, Fogaça MV, Hare B. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0400-x.
Lur G, Higley MJ. Glutamate receptor modulation is restricted to synaptic microdomains. Cell Rep. 2015;12:326–34.
Barkus C, Sanderson DJ, Rawlins JNP, Walton ME, Harrison PJ, Bannerman DM. What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit. Mol Psychiatry. 2014;19:1060–70.
Ripke S, O’Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S, et al. Genome-wide association analysis identifies 14 new risk loci for schizophrenia. Nat Genet. 2013;45:1150–9.
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
Kang WS, Park JK, Kim SK, Park HJ, Lee SM, Song JY, et al. Genetic variants of GRIA1 are associated with susceptibility to schizophrenia in Korean population. Mol Biol Rep. 2012;39:10697–703.
Eastwood SL, McDonald B, Burnet PWJ, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluRl and GluR2 in medial temporal lobe neurons in schizophrenia. Mol Brain Res. 1995;29:211–23.
Eastwood SL, Kerwin RW, Harrison PJ. Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry. 1997;41:636–43.
Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet. 1991;337:450–2.
Breese CR, Freedman R, Leonard SS. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 1995;674:82–90.
Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology. 2007;32:1888–902.
Li W, Ghose S, Gleason K, Begovic A, Perez J, Bartko J, et al. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry. 2015;172:373–82.
Tamminga CA, Southcott S, Sacco C, Wagner AD, Ghose S. Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophr Bull. 2012;38:927–35.
Perez JM, Berto S, Gleason K, Ghose S, Tan C, Kim T-K, et al. Hippocampal subfield transcriptome analysis in schizophrenia psychosis. Mol Psychiatry. 2021;26:2577–89.
Barkus C, Feyder M, Graybeal C, Wright T, Wiedholz L, Izquierdo A, et al. Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? Neuropharmacology. 2011. http://www.sciencedirect.com/science/article/pii/S0028390811002413.
Panayi MC, Boerner T, Jahans-Price T, Huber A, Sprengel R, Gilmour G, et al. Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience. bioRXiv:2021. 2021.07.23.453593. [Preprint]. 2021. Available from: https://www.biorxiv.org/content/10.1101/2021.07.23.453593v1.abstract.
Sanderson DJ, Hindley E, Smeaton E, Denny N, Taylor A, Barkus C, et al. Deletion of the GluA1 AMPA receptor subunit impairs recency-dependent object recognition memory. Learn Mem. 2011;18:181–90.
Sanderson DJ, Sprengel R, Seeburg PH, Bannerman DM. Deletion of the GluA1 AMPA receptor subunit alters the expression of short-term memory. Learn Mem. 2011;18:128–31.
Reisel D, Bannerman DM, Schmitt WB, Deacon RMJ, Flint J, Borchardt T, et al. Spatial memory dissociations in mice lacking GluR1. Nat Neurosci. 2002;5:868–73.
Sanderson DJ, Good MA, Skelton K, Sprengel R, Seeburg PH, Rawlins JNP, et al. Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. Learn Mem. 2009;16:379–86.
Kätzel D, Wolff AR, Bygrave AM, Bannerman DM. Hippocampal hyperactivity as a druggable circuit-level origin of aberrant salience in schizophrenia. Front Pharmacol. 2020;11:1628. https://doi.org/10.3389/fphar.2020.486811.
Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson R-M, Hefner K, et al. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors. Mol Psychiatry. 2007;13:631–40.
Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13–23.
Fond G, Micoulaud-Franchi J-A, Brunel L, Macgregor A, Miot S, Lopez R, et al. Innovative mechanisms of action for pharmaceutical cognitive enhancement: a systematic review. Psychiatry Res. 2015;229:12–20.
Wezenberg E, Jan Verkes R, Ruigt GSF, Hulstijn W, Sabbe BGC. Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers. Neuropsychopharmacology. 2007;32:1272–83.
Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, et al. A placebo-controlled add-on trial of the ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008;33:465–72.
Schmitt WB, Sprengel R, Mack V, Draft RW, Seeburg PH, Deacon RMJ, et al. Restoration of spatial working memory by genetic rescue of GluR-A–deficient mice. Nat Neurosci. 2005;8:270–2.
Mack V, Burnashev N, Kaiser KM, Rozov A, Jensen V, Hvalby O, et al. Conditional restoration of hippocampal synaptic potentiation in Glur-A-deficient mice. Science. 2001;292:2501–4.
Bygrave AM, Jahans-Price T, Wolff AR, Sprengel R, Kullmann DM, Bannerman DM, et al. Hippocampal–prefrontal coherence mediates working memory and selective attention at distinct frequency bands and provides a causal link between schizophrenia and its risk gene GRIA1. Transl Psychiatry. 2019;9:142.
Freudenberg F, Resnik E, Kolleker A, Celikel T, Sprengel R, Seeburg PH. Hippocampal GluA1 expression in Gria1−/− mice only partially restores spatial memory performance deficits. Neurobiol Learn Mem. 2016;135:83–90.
Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, Bannerman DM, et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron. 2007;53:591–604.
Freudenberg F, Marx V, Seeburg PH, Sprengel R, Celikel T. Circuit mechanisms of GluA1-dependent spatial working memory. Hippocampus. 2013;23:1359–66.
Hitti FL, Siegelbaum SA. The hippocampal CA2 region is essential for social memory. Nature. 2014;508:88–92.
Nakazawa K, Quirk MC, Chitwood RA, Watanabe M, Yeckel MF, Sun LD, et al. Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science. 2002;297:211–8.
Grimm CM, Aksamaz S, Schulz S, Teutsch J, Sicinski P, Liss B, et al. Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity. Transl Psychiatry. 2018;8:212.
Kilonzo K, Veen B, van der, Teutsch J, Schulz S, Kapanaiah SKT, Liss B, et al. Delayed-matching-to-position working memory in mice relies on NMDA-receptors in prefrontal pyramidal cells. Sci Rep. 2021;11:1–19.
Bygrave AM, Masiulis S, Nicholson E, Berkemann M, Sprengel R, Harrison P, et al. Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801. Transl Psychiatry. 2016;6:e778.
Teutsch J, Kätzel D. Operant assessment of DMTP spatial working memory in mice. Front Behav Neurosci. 2019;13:193. https://doi.org/10.3389/fnbeh.2019.00193.
van der Veen B, Kapanaiah SKT, Kilonzo K, Steele-Perkins P, Jendryka MM, Schulz S, et al. Control of impulsivity by Gi-protein signalling in layer-5 pyramidal neurons of the anterior cingulate cortex. Commun Biol. 2021;4:1–16.
Kapanaiah SKT, van der Veen B, Strahnen D, Akam T, Kätzel D. A low-cost open-source 5-choice operant box system optimized for electrophysiology and optophysiology in mice. Sci Rep. 2021;11:22279.
Akam T, Lustig A, Rowland JM, Kapanaiah SK, Esteve-Agraz J, Panniello M, et al. Open-source, Python-based, hardware and software for controlling behavioural neuroscience experiments. eLife. 2022;11:e67846.
Fitzgerald PJ, Barkus C, Feyder M, Wiedholz LM, Chen Y-C, Karlsson R-M, et al. Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis. 2010;40:608–21.
Boerner T, Bygrave AM, Chen J, Fernando A, Jackson S, Barkus C, et al. The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice. Eur J Neurosci. 2017;45:912–21.
Bannerman DM, Bus T, Taylor A, Sanderson DJ, Schwarz I, Jensen V, et al. Dissecting spatial knowledge from spatial choice by hippocampal NMDA receptor deletion. Nat Neurosci. 2012;15:1153–9.
Sanderson DJ, Bannerman DM. The role of habituation in hippocampus-dependent spatial working memory tasks: evidence from GluA1 AMPA receptor subunit knockout mice. Hippocampus. 2012;22:981–94.
Strahnen D, Kapanaiah SKT, Bygrave AM, Liss B, Bannerman DM, Akam T, et al. Highly task-specific and distributed neural connectivity in working memory revealed by single-trial decoding in mice and humans. bioRxiv: 2021.04.20.440621. [Preprint]. 2021. Available from: https://www.biorxiv.org/content/10.1101/2021.04.20.440621v1.full.
Spitzer M. A neurocomputational approach to delusions. Compr Psychiatry. 1995;36:83–105.
Bienkowski MS, Bowman I, Song MY, Gou L, Ard T, Cotter K, et al. Integration of gene expression and brain-wide connectivity reveals the multiscale organization of mouse hippocampal networks. Nat Neurosci. 2018;21:1628–43.
Chen S, He L, Huang AJY, Boehringer R, Robert V, Wintzer ME, et al. A hypothalamic novelty signal modulates hippocampal memory. Nature. 2020;586:270–4.
Donegan ML, Stefanini F, Meira T, Gordon JA, Fusi S, Siegelbaum SA. Coding of social novelty in the hippocampal CA2 region and its disruption and rescue in a 22q11.2 microdeletion mouse model. Nat Neurosci. 2020;23:1365–75.
Middleton SJ, McHugh TJ. CA2: a highly connected intrahippocampal relay. Annu Rev Neurosci. 2020;43:55–72.
Katthagen T, Dammering F, Kathmann N, Kaminski J, Walter H, Heinz A, et al. Validating the construct of aberrant salience in schizophrenia—behavioral evidence for an automatic process. Schizophr Res Cogn. 2016;6:22–27.
Avery SN, McHugo M, Armstrong K, Blackford JU, Woodward ND, Heckers S. Disrupted habituation in the early stage of psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:1004–12.
Williams LE, Blackford JU, Luksik A, Gauthier I, Heckers S. Reduced habituation in patients with schizophrenia. Schizophr Res. 2013;151:124–32.
Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci. 2010;13:76–83.
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133–40.
Hunker AC, Soden ME, Krayushkina D, Heymann G, Awatramani R, Zweifel LS. Conditional single vector CRISPR/SaCas9 viruses for efficient mutagenesis in the adult mouse nervous system. Cell Rep. 2020;30:4303–.e6.
Chudasama Y, Passetti F, Rhodes SEV, Lopian D, Desai A, Robbins TW. Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res. 2003;146:105–19.
Muir JL, Everitt BJ, Robbins TW. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex. 1996;6:470–81.
Murphy ER, Fernando ABP, Urcelay GP, Robinson ESJ, Mar AC, Theobald DEH, et al. Impulsive behaviour induced by both NMDA receptor antagonism and GABAA receptor activation in rat ventromedial prefrontal cortex. Psychopharmacology. 2012;219:401–10.
Tobias Bast, Marie Pezze. McGarrity stephanie. Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition. Br J Pharm. 2017;174:3211–25.
Tan Z, Robinson HL, Yin D-M, Liu Y, Liu F, Wang H, et al. Dynamic ErbB4 activity in hippocampal-prefrontal synchrony and top-down attention in rodents. Neuron. 2018;98:380–.e4.
Finlay JM, Dunham GA, Isherwood AM, Newton CJ, Nguyen TV, Reppar PC, et al. Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviors. Brain Res. 2015;1600:70–83.
Romberg C, Raffel J, Martin L, Sprengel R, Seeburg PH, Rawlins JNP, et al. Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus. Eur J Neurosci. 2009;29:1141–52.
Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation in the hippocampus. Science. 2006;313:1093–7.
Selcher JC, Xu W, Hanson JE, Malenka RC, Madison DV. Glutamate receptor subunit GluA1 is necessary for long-term potentiation and synapse unsilencing, but not long-term depression in mouse hippocampus. Brain Res. 2012;1435:8–14.
Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004;363:2063–72.
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86–97.
Arai AC, Kessler M. Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets. 2007;8:583–602.
Ingvar M, Ambros-Ingerson J, Davis M, Granger R, Kessler M, Rogers GA, et al. Enhancement by an ampakine of memory encoding in humans. Exp Neurol. 1997;146:553–9.
Lynch G, Granger R, Ambros-Ingerson J, Davis CM, Kessler M, Schehr R. Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Exp Neurol. 1997;145:89–92.
Ranganathan M, DeMartinis N, Huguenel B, Gaudreault F, Bednar MM, Shaffer CL, et al. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242. Mol Psychiatry. 2017;22:1633–40.
Tanaka M, Kunugi A, Suzuki A, Suzuki N, Suzuki M, Kimura H. Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia. Pharm Res Perspect. 2019;7:e00479.
Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry. 2010;167:1178–93.
Harrison PJ. Recent genetic findings in schizophrenia and their therapeutic relevance. J Psychopharmacol. 2015;29:85–96.
We thank Dr. Volker Mack (Boehringer Ingelheim) for advice on histology and Dr. Sviatlana Kalinina (Ulm University) for assistance with confocal microscopy. This work was funded by the LGFG scholarship programme of Baden-Württemberg (to KK), the Ingeborg Ständer Stiftung (to RS), the Else-Kroener-Fresenius/German-Scholars-Organization Programme for excellent medical scientists from abroad (GSO/EKFS 12; to DK), the Juniorprofessorship programme of Baden-Württemberg (to DK), and the DFG (KA 4594/2-1; to DK).
Open Access funding enabled and organized by Projekt DEAL
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kilonzo, K., Strahnen, D., Prex, V. et al. Distinct contributions of GluA1-containing AMPA receptors of different hippocampal subfields to salience processing, memory and impulse control. Transl Psychiatry 12, 102 (2022). https://doi.org/10.1038/s41398-022-01863-8